Gosling Rebecca C, Morris Paul D, Lawford Patricia V, Hose D Rodney, Gunn Julian P
Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Department of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, United Kingdom.
Front Physiol. 2018 Aug 13;9:1107. doi: 10.3389/fphys.2018.01107. eCollection 2018.
Computational modeling has been used routinely in the pre-clinical development of medical devices such as coronary artery stents. The ability to simulate and predict physiological and structural parameters such as flow disturbance, wall shear-stress, and mechanical strain patterns is beneficial to stent manufacturers. These methods are now emerging as useful clinical tools, used by physicians in the assessment and management of patients. Computational models, which can predict the physiological response to intervention, offer clinicians the ability to evaluate a number of different treatment strategies prior to treating the patient in the cardiac catheter laboratory. For the first time clinicians can perform a patient-specific assessment prior to making treatment decisions. This could be advantageous in patients with complex disease patterns where the optimal treatment strategy is not clear. This article reviews the key advances and the potential barriers to clinical adoption and translation of these virtual treatment planning models.
计算建模已常规用于冠状动脉支架等医疗设备的临床前开发。模拟和预测诸如血流紊乱、壁面剪应力和机械应变模式等生理和结构参数的能力对支架制造商有益。这些方法现在正成为有用的临床工具,供医生用于患者的评估和管理。能够预测对干预的生理反应的计算模型,使临床医生有能力在心脏导管实验室对患者进行治疗之前评估多种不同的治疗策略。临床医生首次能够在做出治疗决定之前进行针对患者的评估。这对于疾病模式复杂且最佳治疗策略不明确的患者可能具有优势。本文综述了这些虚拟治疗规划模型在临床应用和转化方面的关键进展以及潜在障碍。